Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002118:Calcium / Q000097:blood / Q000652:urine; D000242:Cyclic AMP / Q000652:urine; D012968:Etidronic Acid / Q000008:administration & dosage / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007668:Kidney / Q000378:metabolism; D007669:Kidney Calculi / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010758:Phosphorus / Q000652:urine; D013997:Time Factors; D014545:Urinary Calculi / Q000188:drug therapy / Q000378:metabolism
D009943:Organophosphorus Compounds; D010758:Phosphorus; D000242:Cyclic AMP; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D012968:Etidronic Acid; D002118:Calcium